位置:首页 > 蛋白库 > RHAG_HUMAN
RHAG_HUMAN
ID   RHAG_HUMAN              Reviewed;         409 AA.
AC   Q02094; B2R8T8; O43514; O43515; Q7L8L3; Q9H454;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   03-AUG-2022, entry version 186.
DE   RecName: Full=Ammonium transporter Rh type A;
DE   AltName: Full=Erythrocyte membrane glycoprotein Rh50;
DE   AltName: Full=Erythrocyte plasma membrane 50 kDa glycoprotein;
DE            Short=Rh50A;
DE   AltName: Full=Rhesus blood group family type A glycoprotein;
DE            Short=Rh family type A glycoprotein;
DE            Short=Rh type A glycoprotein;
DE   AltName: Full=Rhesus blood group-associated ammonia channel;
DE   AltName: Full=Rhesus blood group-associated glycoprotein;
DE   AltName: CD_antigen=CD241;
GN   Name=RHAG; Synonyms=RH50;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ASP-242.
RC   TISSUE=Bone marrow, and Liver;
RX   PubMed=1417776; DOI=10.1042/bj2870223;
RA   Ridgwell K., Spurr N.K., Laguda B., Macgeoch C., Avent N.D., Tanner M.J.A.;
RT   "Isolation of cDNA clones for a 50 kDa glycoprotein of the human
RT   erythrocyte membrane associated with Rh (rhesus) blood-group antigen
RT   expression.";
RL   Biochem. J. 287:223-228(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=9442063; DOI=10.1074/jbc.273.4.2207;
RA   Huang C.-H.;
RT   "The human Rh50 glycoprotein gene. Structural organization and associated
RT   splicing defect resulting in Rh(null) disease.";
RL   J. Biol. Chem. 273:2207-2213(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ILE-270.
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-52, AND TISSUE SPECIFICITY.
RX   PubMed=9473510; DOI=10.1006/bbrc.1997.8023;
RA   Iwamoto S., Omi T., Yamasaki M., Okuda H., Kawano M., Kajii E.;
RT   "Identification of 5' flanking sequence of RH50 gene and the core region
RT   for erythroid-specific expression.";
RL   Biochem. Biophys. Res. Commun. 243:233-240(1998).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-39.
RX   PubMed=3146980; DOI=10.1042/bj2561043;
RA   Avent N.D., Ridgwell K., Mawby W.J., Tanner M.J.A., Anstee D.J., Kumpel B.;
RT   "Protein-sequence studies on Rh-related polypeptides suggest the presence
RT   of at least two groups of proteins which associate in the human red-cell
RT   membrane.";
RL   Biochem. J. 256:1043-1046(1988).
RN   [8]
RP   FUNCTION.
RX   PubMed=11062476; DOI=10.1038/81656;
RA   Marini A.-M., Matassi G., Raynal V., Andre B., Cartron J.-P.,
RA   Cherif-Zahar B.;
RT   "The human Rhesus-associated RhAG protein and a kidney homologue promote
RT   ammonium transport in yeast.";
RL   Nat. Genet. 26:341-344(2000).
RN   [9]
RP   FUNCTION.
RX   PubMed=11861637; DOI=10.1074/jbc.c200060200;
RA   Westhoff C.M., Ferreri-Jacobia M., Mak D.-O.D., Foskett J.K.;
RT   "Identification of the erythrocyte Rh blood group glycoprotein as a
RT   mammalian ammonium transporter.";
RL   J. Biol. Chem. 277:12499-12502(2002).
RN   [10]
RP   CHARACTERIZATION.
RX   PubMed=14966114; DOI=10.1074/jbc.m311853200;
RA   Westhoff C.M., Siegel D.L., Burd C.G., Foskett J.K.;
RT   "Mechanism of genetic complementation of ammonium transport in yeast by
RT   human erythrocyte Rh-associated glycoprotein.";
RL   J. Biol. Chem. 279:17443-17448(2004).
RN   [11]
RP   VARIANT RHN ASN-79.
RX   PubMed=8563755; DOI=10.1038/ng0296-168;
RA   Cherif-Zahar B., Raynal V., Gane P., Mattei M.-G., Bailly P., Gibbs B.,
RA   Colin Y., Cartron J.-P.;
RT   "Candidate gene acting as a suppressor of the RH locus in most cases of Rh-
RT   deficiency.";
RL   Nat. Genet. 12:168-173(1996).
RN   [12]
RP   VARIANT RHN GLU-279.
RX   PubMed=9454778;
RA   Hyland C.A., Cherif-Zahar B., Cowley N., Raynal V., Parkes J., Saul A.,
RA   Cartron J.-P.;
RT   "A novel single missense mutation identified along the RH50 gene in a
RT   composite heterozygous Rhnull blood donor of the regulator type.";
RL   Blood 91:1458-1463(1998).
RN   [13]
RP   VARIANT RHN GLU-279.
RX   PubMed=9716608;
RA   Huang C.-H., Liu Z., Cheng G., Chen Y.;
RT   "Rh50 glycoprotein gene and rhnull disease: a silent splice donor is trans
RT   to a Gly279-->Glu missense mutation in the conserved transmembrane
RT   segment.";
RL   Blood 92:1776-1784(1998).
RN   [14]
RP   VARIANTS RHN ARG-280 AND VAL-380, AND VARIANT ILE-270.
RX   PubMed=10467273;
RX   DOI=10.1002/(sici)1096-8652(199909)62:1<25::aid-ajh5>3.0.co;2-k;
RA   Huang C.-H., Cheng G., Liu Z., Chen Y., Reid M.E., Halverson G., Okubo Y.;
RT   "Molecular basis for Rh(null) syndrome: identification of three new
RT   missense mutations in the Rh50 glycoprotein gene.";
RL   Am. J. Hematol. 62:25-32(1999).
RN   [15]
RP   INVOLVEMENT IN OHST, VARIANTS OHST ARG-61 AND SER-65, CHARACTERIZATION OF
RP   VARIANTS OHST ARG-61 AND SER-65, FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, AND GLYCOSYLATION.
RX   PubMed=18931342; DOI=10.1182/blood-2008-07-171140;
RA   Bruce L.J., Guizouarn H., Burton N.M., Gabillat N., Poole J., Flatt J.F.,
RA   Brady R.L., Borgese F., Delaunay J., Stewart G.W.;
RT   "The monovalent cation leak in overhydrated stomatocytic red blood cells
RT   results from amino acid substitutions in the Rh-associated glycoprotein.";
RL   Blood 113:1350-1357(2009).
RN   [16]
RP   VARIANTS GLU-106; GLN-164 AND LEU-227, AND FUNCTION.
RX   PubMed=19744193; DOI=10.1111/j.1423-0410.2009.01243.x;
RA   Tilley L., Green C., Poole J., Gaskell A., Ridgwell K., Burton N.M.,
RA   Uchikawa M., Tsuneyama H., Ogasawara K., Akkoek C.A., Daniels G.;
RT   "A new blood group system, RHAG: three antigens resulting from amino acid
RT   substitutions in the Rh-associated glycoprotein.";
RL   Vox Sang. 98:151-159(2010).
RN   [17]
RP   VARIANT OHST SER-65, CHARACTERIZATION OF VARIANT OHST SER-65, AND FUNCTION.
RX   PubMed=21849667; DOI=10.1152/ajpcell.00054.2011;
RA   Stewart A.K., Shmukler B.E., Vandorpe D.H., Rivera A., Heneghan J.F.,
RA   Li X., Hsu A., Karpatkin M., O'Neill A.F., Bauer D.E., Heeney M.M.,
RA   John K., Kuypers F.A., Gallagher P.G., Lux S.E., Brugnara C.,
RA   Westhoff C.M., Alper S.L.;
RT   "Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant
RT   RhAG F65S.";
RL   Am. J. Physiol. 301:C1325-C1343(2011).
RN   [18]
RP   CHARACTERIZATION OF VARIANT OHST SER-65, FUNCTION, SUBCELLULAR LOCATION,
RP   GLYCOSYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=22012326; DOI=10.1152/ajpcell.00092.2011;
RA   Genetet S., Ripoche P., Picot J., Bigot S., Delaunay J., Armari-Alla C.,
RA   Colin Y., Mouro-Chanteloup I.;
RT   "Human RhAG ammonia channel is impaired by the Phe65Ser mutation in
RT   overhydrated stomatocytic red cells.";
RL   Am. J. Physiol. 302:C419-C428(2012).
RN   [19]
RP   VARIANT ILE-270.
RX   PubMed=27535533; DOI=10.1038/nature19057;
RG   Exome Aggregation Consortium;
RA   Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E., Fennell T.,
RA   O'Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B., Tukiainen T.,
RA   Birnbaum D.P., Kosmicki J.A., Duncan L.E., Estrada K., Zhao F., Zou J.,
RA   Pierce-Hoffman E., Berghout J., Cooper D.N., Deflaux N., DePristo M.,
RA   Do R., Flannick J., Fromer M., Gauthier L., Goldstein J., Gupta N.,
RA   Howrigan D., Kiezun A., Kurki M.I., Moonshine A.L., Natarajan P.,
RA   Orozco L., Peloso G.M., Poplin R., Rivas M.A., Ruano-Rubio V., Rose S.A.,
RA   Ruderfer D.M., Shakir K., Stenson P.D., Stevens C., Thomas B.P., Tiao G.,
RA   Tusie-Luna M.T., Weisburd B., Won H.H., Yu D., Altshuler D.M.,
RA   Ardissino D., Boehnke M., Danesh J., Donnelly S., Elosua R., Florez J.C.,
RA   Gabriel S.B., Getz G., Glatt S.J., Hultman C.M., Kathiresan S., Laakso M.,
RA   McCarroll S., McCarthy M.I., McGovern D., McPherson R., Neale B.M.,
RA   Palotie A., Purcell S.M., Saleheen D., Scharf J.M., Sklar P.,
RA   Sullivan P.F., Tuomilehto J., Tsuang M.T., Watkins H.C., Wilson J.G.,
RA   Daly M.J., MacArthur D.G.;
RT   "Analysis of protein-coding genetic variation in 60,706 humans.";
RL   Nature 536:285-291(2016).
CC   -!- FUNCTION: Associated with rhesus blood group antigen expression
CC       (PubMed:19744193). May be part of an oligomeric complex which is likely
CC       to have a transport or channel function in the erythrocyte membrane
CC       (PubMed:11062476, PubMed:11861637). Involved in ammonia transport
CC       across the erythrocyte membrane (PubMed:21849667, PubMed:22012326).
CC       Seems to act in monovalent cation transport (PubMed:18931342,
CC       PubMed:21849667). {ECO:0000269|PubMed:11062476,
CC       ECO:0000269|PubMed:11861637, ECO:0000269|PubMed:18931342,
CC       ECO:0000269|PubMed:19744193, ECO:0000269|PubMed:21849667,
CC       ECO:0000269|PubMed:22012326}.
CC   -!- SUBUNIT: Heterotetramer.
CC   -!- INTERACTION:
CC       Q02094; Q68CJ9: CREB3L3; NbExp=3; IntAct=EBI-14772355, EBI-852194;
CC       Q02094; Q9Y282: ERGIC3; NbExp=3; IntAct=EBI-14772355, EBI-781551;
CC       Q02094; Q5JX71: FAM209A; NbExp=3; IntAct=EBI-14772355, EBI-18304435;
CC       Q02094; Q8N6K0: TEX29; NbExp=3; IntAct=EBI-14772355, EBI-19027521;
CC       Q02094; Q86WB7-2: UNC93A; NbExp=3; IntAct=EBI-14772355, EBI-13356252;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:18931342,
CC       ECO:0000269|PubMed:22012326}; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q02094-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q02094-2; Sequence=VSP_047629, VSP_047630;
CC   -!- TISSUE SPECIFICITY: Erythrocytes. {ECO:0000269|PubMed:18931342,
CC       ECO:0000269|PubMed:22012326, ECO:0000269|PubMed:9473510}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:18931342,
CC       ECO:0000269|PubMed:22012326}.
CC   -!- DISEASE: Regulator type Rh-null hemolytic anemia (RHN) [MIM:268150]:
CC       Form of chronic hemolytic anemia in which the red blood cells have a
CC       stomatocytosis and spherocytosis morphology, an increased osmotic
CC       fragility, an altered ion transport system, and abnormal membrane
CC       phospholipid organization. {ECO:0000269|PubMed:10467273,
CC       ECO:0000269|PubMed:8563755, ECO:0000269|PubMed:9454778,
CC       ECO:0000269|PubMed:9716608}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Overhydrated hereditary stomatocytosis (OHST) [MIM:185000]: An
CC       autosomal dominant disorder of red cell membrane permeability to
CC       monovalent cations, characterized by macrocytic hemolytic anemia of
CC       fluctuating severity, circulating erythrocytes with slit-like lucencies
CC       (stomata) evident on fixed, stained peripheral blood smears. OHST red
CC       cells exhibit cation leak, resulting in elevated cell sodium content
CC       with reduced potassium content. The disease is marked by splenomegaly
CC       or hepatosplenomegaly, cholelithiasis and a strong tendency for iron
CC       overload. {ECO:0000269|PubMed:18931342, ECO:0000269|PubMed:21849667,
CC       ECO:0000269|PubMed:22012326}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ammonium transporter (TC 2.A.49) family. Rh
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X64594; CAA45883.1; -; mRNA.
DR   EMBL; AF031548; AAC04247.1; -; mRNA.
DR   EMBL; AF031549; AAC04248.1; -; mRNA.
DR   EMBL; AF237387; AAF78209.1; -; Genomic_DNA.
DR   EMBL; AF237382; AAF78209.1; JOINED; Genomic_DNA.
DR   EMBL; AF237383; AAF78209.1; JOINED; Genomic_DNA.
DR   EMBL; AF237384; AAF78209.1; JOINED; Genomic_DNA.
DR   EMBL; AF237385; AAF78209.1; JOINED; Genomic_DNA.
DR   EMBL; AF237386; AAF78209.1; JOINED; Genomic_DNA.
DR   EMBL; AK313505; BAG36285.1; -; mRNA.
DR   EMBL; AL121950; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590244; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX04337.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04338.1; -; Genomic_DNA.
DR   CCDS; CCDS4927.1; -. [Q02094-1]
DR   PIR; S29124; S29124.
DR   RefSeq; NP_000315.2; NM_000324.2. [Q02094-1]
DR   AlphaFoldDB; Q02094; -.
DR   SMR; Q02094; -.
DR   BioGRID; 111937; 7.
DR   IntAct; Q02094; 5.
DR   STRING; 9606.ENSP00000360217; -.
DR   TCDB; 1.A.11.4.3; the ammonium transporter channel (amt) family.
DR   GlyGen; Q02094; 3 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q02094; -.
DR   PhosphoSitePlus; Q02094; -.
DR   BioMuta; RHAG; -.
DR   DMDM; 218511807; -.
DR   jPOST; Q02094; -.
DR   MassIVE; Q02094; -.
DR   PaxDb; Q02094; -.
DR   PeptideAtlas; Q02094; -.
DR   PRIDE; Q02094; -.
DR   ProteomicsDB; 58049; -. [Q02094-1]
DR   Antibodypedia; 17000; 63 antibodies from 23 providers.
DR   DNASU; 6005; -.
DR   Ensembl; ENST00000371175.10; ENSP00000360217.4; ENSG00000112077.18. [Q02094-1]
DR   Ensembl; ENST00000646939.1; ENSP00000494709.1; ENSG00000112077.18. [Q02094-2]
DR   GeneID; 6005; -.
DR   KEGG; hsa:6005; -.
DR   MANE-Select; ENST00000371175.10; ENSP00000360217.4; NM_000324.3; NP_000315.2.
DR   UCSC; uc003ozk.5; human. [Q02094-1]
DR   CTD; 6005; -.
DR   DisGeNET; 6005; -.
DR   GeneCards; RHAG; -.
DR   HGNC; HGNC:10006; RHAG.
DR   HPA; ENSG00000112077; Tissue enriched (bone).
DR   MalaCards; RHAG; -.
DR   MIM; 180297; gene.
DR   MIM; 185000; phenotype.
DR   MIM; 268150; phenotype.
DR   neXtProt; NX_Q02094; -.
DR   OpenTargets; ENSG00000112077; -.
DR   Orphanet; 3203; Overhydrated hereditary stomatocytosis.
DR   Orphanet; 71275; Rh deficiency syndrome.
DR   PharmGKB; PA34381; -.
DR   VEuPathDB; HostDB:ENSG00000112077; -.
DR   eggNOG; KOG3796; Eukaryota.
DR   GeneTree; ENSGT00950000182844; -.
DR   InParanoid; Q02094; -.
DR   OMA; EITIFAC; -.
DR   PhylomeDB; Q02094; -.
DR   TreeFam; TF314450; -.
DR   PathwayCommons; Q02094; -.
DR   Reactome; R-HSA-1237044; Erythrocytes take up carbon dioxide and release oxygen.
DR   Reactome; R-HSA-1247673; Erythrocytes take up oxygen and release carbon dioxide.
DR   Reactome; R-HSA-444411; Rhesus glycoproteins mediate ammonium transport.
DR   Reactome; R-HSA-5619042; Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN).
DR   SignaLink; Q02094; -.
DR   SIGNOR; Q02094; -.
DR   BioGRID-ORCS; 6005; 3 hits in 1073 CRISPR screens.
DR   ChiTaRS; RHAG; human.
DR   GeneWiki; RHAG; -.
DR   GenomeRNAi; 6005; -.
DR   Pharos; Q02094; Tbio.
DR   PRO; PR:Q02094; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q02094; protein.
DR   Bgee; ENSG00000112077; Expressed in trabecular bone tissue and 116 other tissues.
DR   ExpressionAtlas; Q02094; baseline and differential.
DR   Genevisible; Q02094; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008519; F:ammonium transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0030506; F:ankyrin binding; IPI:UniProtKB.
DR   GO; GO:0035379; F:carbon dioxide transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0022840; F:leak channel activity; IDA:UniProtKB.
DR   GO; GO:0097272; P:ammonium homeostasis; IBA:GO_Central.
DR   GO; GO:0072488; P:ammonium transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0015701; P:bicarbonate transport; TAS:Reactome.
DR   GO; GO:0015670; P:carbon dioxide transport; IDA:UniProtKB.
DR   GO; GO:0006873; P:cellular ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0048821; P:erythrocyte development; IEA:Ensembl.
DR   GO; GO:0098662; P:inorganic cation transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0060586; P:multicellular organismal iron ion homeostasis; IEA:Ensembl.
DR   Gene3D; 1.10.3430.10; -; 1.
DR   InterPro; IPR029020; Ammonium/urea_transptr.
DR   InterPro; IPR024041; NH4_transpt_AmtB-like_dom.
DR   InterPro; IPR002229; RhesusRHD.
DR   Pfam; PF00909; Ammonium_transp; 1.
DR   PRINTS; PR00342; RHESUSRHD.
PE   1: Evidence at protein level;
KW   Alternative splicing; Ammonia transport; Direct protein sequencing;
KW   Disease variant; Glycoprotein; Hereditary hemolytic anemia; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..409
FT                   /note="Ammonium transporter Rh type A"
FT                   /id="PRO_0000168199"
FT   TOPO_DOM        1..2
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        3..23
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        24..51
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        52..72
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        73..79
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        80..100
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        101..113
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        114..134
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        135..142
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        143..163
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        164..167
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        168..188
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        189..208
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        209..229
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        230..239
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        240..260
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        261..268
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        269..291
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        292..295
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        296..318
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        319..332
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        333..353
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        354..362
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        363..383
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        384..409
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        37
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        355
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         316..351
FT                   /note="PLFTTKLRIHDTCGVHNLHGLPGVVGGLAGIVAVAM -> VYGHAGSCTGFL
FT                   YRNSSCWRSDDRFNSKVASLGTAI (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9442063"
FT                   /id="VSP_047629"
FT   VAR_SEQ         352..409
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9442063"
FT                   /id="VSP_047630"
FT   VARIANT         61
FT                   /note="I -> R (in OHST; strongly enhances monovalent cation
FT                   leak; dbSNP:rs863225469)"
FT                   /evidence="ECO:0000269|PubMed:18931342"
FT                   /id="VAR_076283"
FT   VARIANT         65
FT                   /note="F -> S (in OHST; enhances monovalent cation leak;
FT                   decreases ammonium fluxes; highly decreases STOM
FT                   expression; decreases membrane expression; no effect on
FT                   water permeability; dbSNP:rs863225468)"
FT                   /evidence="ECO:0000269|PubMed:18931342,
FT                   ECO:0000269|PubMed:21849667, ECO:0000269|PubMed:22012326"
FT                   /id="VAR_076284"
FT   VARIANT         79
FT                   /note="S -> N (in RHN; dbSNP:rs121918586)"
FT                   /evidence="ECO:0000269|PubMed:8563755"
FT                   /id="VAR_006921"
FT   VARIANT         106
FT                   /note="Q -> E (in Duclos or RHAG1 antigen (030001);
FT                   dbSNP:rs1180686517)"
FT                   /evidence="ECO:0000269|PubMed:19744193"
FT                   /id="VAR_076285"
FT   VARIANT         164
FT                   /note="K -> Q (in DSLK or RHAG3 antigen (030003);
FT                   dbSNP:rs144305805)"
FT                   /evidence="ECO:0000269|PubMed:19744193"
FT                   /id="VAR_076286"
FT   VARIANT         227
FT                   /note="S -> L (in Ol(a) or RHAG2 antigen (030002);
FT                   dbSNP:rs902283342)"
FT                   /evidence="ECO:0000269|PubMed:19744193"
FT                   /id="VAR_076287"
FT   VARIANT         242
FT                   /note="N -> D (in dbSNP:rs1058063)"
FT                   /evidence="ECO:0000269|PubMed:1417776"
FT                   /id="VAR_047999"
FT   VARIANT         270
FT                   /note="V -> I (in dbSNP:rs16879498)"
FT                   /evidence="ECO:0000269|PubMed:10467273,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:27535533"
FT                   /id="VAR_015855"
FT   VARIANT         279
FT                   /note="G -> E (in RHN; dbSNP:rs121918587)"
FT                   /evidence="ECO:0000269|PubMed:9454778,
FT                   ECO:0000269|PubMed:9716608"
FT                   /id="VAR_015856"
FT   VARIANT         280
FT                   /note="G -> R (in RHN; dbSNP:rs104893987)"
FT                   /evidence="ECO:0000269|PubMed:10467273"
FT                   /id="VAR_015857"
FT   VARIANT         380
FT                   /note="G -> V (in RHN; dbSNP:rs121918589)"
FT                   /evidence="ECO:0000269|PubMed:10467273"
FT                   /id="VAR_015858"
FT   CONFLICT        2
FT                   /note="R -> C (in Ref. 7; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        37
FT                   /note="N -> P (in Ref. 7; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   409 AA;  44198 MW;  F6F024399CC0C88D CRC64;
     MRFTFPLMAI VLEIAMIVLF GLFVEYETDQ TVLEQLNITK PTDMGIFFEL YPLFQDVHVM
     IFVGFGFLMT FLKKYGFSSV GINLLVAALG LQWGTIVQGI LQSQGQKFNI GIKNMINADF
     SAATVLISFG AVLGKTSPTQ MLIMTILEIV FFAHNEYLVS EIFKASDIGA SMTIHAFGAY
     FGLAVAGILY RSGLRKGHEN EESAYYSDLF AMIGTLFLWM FWPSFNSAIA EPGDKQCRAI
     VNTYFSLAAC VLTAFAFSSL VEHRGKLNMV HIQNATLAGG VAVGTCADMA IHPFGSMIIG
     SIAGMVSVLG YKFLTPLFTT KLRIHDTCGV HNLHGLPGVV GGLAGIVAVA MGASNTSMAM
     QAAALGSSIG TAVVGGLMTG LILKLPLWGQ PSDQNCYDDS VYWKVPKTR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024